|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 92.08 USD | +3.17% |
|
+9.41% | +16.66% |
| Apr. 18 | Transmedics Group Insider Sold Shares Worth $380,480, According to a Recent SEC Filing | MT |
| Apr. 05 | Transmedics Group Insider Sold Shares Worth $802,084, According to a Recent SEC Filing | MT |
TransMedics Group, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was USD 241.62 million compared to USD 93.46 million a year ago. Net loss was USD 25.03 million compared to USD 36.23 million a year ago.
Basic loss per share from continuing operations was USD 0.77 compared to USD 1.23 a year ago. Diluted loss per share from continuing operations was USD 0.77 compared to USD 1.23 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +16.66% | 3.02B | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B | |
| +26.76% | 32.03B |
TRANSMEDICS GROUP, INC. 
